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Edited by David LambethAbstract Hypoxia is a common environmental stress factor and
is also associated with various physiological and pathological
conditions such as ﬁbrogenesis. The activation of hepatic stellate
cells (HSCs) is the key event in the liver ﬁbrogenesis. In this
study, the behavior of human HSCs LX-2 in low oxygen tension
(1% O2) was analyzed. Upon hypoxia, the expression of HIF-1a
and VEGF gene was induced. The result of Western blotting
showed that the expression of a-SMA was increased by hypoxic
stimulation. Furthermore, the expression of MMP-2 and TIMP-
1 genes was increased. Hypoxia also elevated the protein expres-
sion of the collagen type I in LX-2 cells. The analysis of TGF-b/
Smad signaling pathway showed that hypoxia potentiated the
expression of TGF-b1 and the phosphorylation status of Smad2.
Gene expression proﬁles of LX-2 cells induced by hypoxia were
obtained by using cDNA microarray technique.
 2006 Federation of European Biochemical Societies. Published
by Elsevier B.V. All rights reserved.
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Oxygen has important functions as substrate for biochemical
reactions and as modulator of gene expression. A failure with-
in O2 delivering system may contribute to the pathophysiology
of common diseases, including chronic lung disease, myocar-
dial infarction, stroke, ﬁbrosis and cancer [1]. In the liver,
the physiologically occurring oxygen gradient is a major
eﬀecter of metabolic zonation. Under pathological situations,
hypoxia appears to be a major determinant for liver diseases
including ﬁbrosis and cancer. Furthermore, cellular hypoxia
is a key feature of alcoholic liver injury [2].
Hepatic ﬁbrosis is a common response to various chronic he-
patic injuries, characterized by the deposition of extracellular
matrix (ECM). It is well known that the key event in the hepa-
tic ﬁbrogenesis is the activation of hepatic stellate cells due to
altered circumstances. The hepatic stellate cells (HSCs), spe-
ciﬁc pericytes located in the subendothelial space between theAbbreviations: HSCs, hepatic stellate cells; TGF-b1, transforming
growth factor-b1; ECM, extracellular matrix; MMP, metalloprotein-
ase; TIMP, tissue inhibitor of metalloproteinase
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lial cells [3], are the principle source of ECM during chronic
liver injury. Under stimulation, HSCs undergo a transition
from a quiescent to an activated phenotype [4]. Activated he-
patic stellate cells are involved in cell proliferation, increased
contractility, enhanced matrix production, and expression of
a number of ﬁbrogenic and proliferative cytokines and their
cognate receptors [5]. In addition, activation of HSCs occurs
as a response to chronic liver injury associated with consider-
able loss of functional hepatocellular tissue. LX-2 is a low-pas-
saged human hepatic stellate cell line derived from normal
human stellate cells that are spontaneously immortalized [6].
LX-2 cells were selected by their ability to grow under the
low serum conditions (1% fetal bovine serum). The cells exhibit
the typical features of HSCs in primary culture, expressing des-
min, glial acidic ﬁbrillary protein, and responsiveness to plate-
let-derived growth factor BB and transforming growth factor-
b1 (TGF-b1). The cells express smooth muscle-a-actin (a-
SMA) under all culture conditions and therefore were regarded
as at least partially activated even after immediate replating
[6].
Although oxygen is essential for cell living and hypoxia will
lead to cell dysfunction or even death, hypoxia always happens
during liver damage and inﬂammation. In this study, the eﬀect
of hypoxia on HSCs, which serve as major oxygen-sensing
cells, was studied by various cellular and molecular biology
techniques. LX-2 cells were activated under the treatment of
low oxygen tension and the expression of hypoxia-responsive
genes and HSCs activation-related genes were measured. Fur-
thermore, gene expression proﬁling of LX-2 cells induced by
low oxygen tension was carried out by using cDNA micro-
array technique to investigate the molecular mechanisms of
HSCs in response to hypoxia.2. Materials and methods
2.1. Materials
Dulbecco’s modiﬁed Eagle’s medium (DMEM) and Trizol reagent
were from Invitrogen Corporation (Carlsbad, CA). Penicillin–strepto-
mycin, fetal bovine serum, trypsin-EDTA were from Gibco (Gibco
BRL, CA). Mouse monoclonal anti-collagen type I antibody was pur-
chased from Calbiochem (Calbiochem, Germany). Mouse monoclonal
anti-a-SMA antibody was purchased from DakoCytomation (Dako,
Denmark). Rabbit monoclonal anti-phospho-Smad2 antibody was
purchased from Cell Signaling Technology (Cell Signaling, USA). Per-
oxidase-conjugated anti-goat secondary antibody were from Santa
Cruz Biotech (Santa Cruz, CA).blished by Elsevier B.V. All rights reserved.
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Human HSC cell line, LX-2, was been described previously [6]. LX-2
cells were cultured at 37 C in a humidiﬁed atmosphere containing 5%
CO2 with Dulbecco’s modiﬁed Eagle’s medium (DMEM) containing
10% fetal bovine serum, 100 U of penicillin and 100 lg of streptomycin
(all from Gibco BRL, CA). For hypoxia stimulation, the cells were ser-
um-starved for 24 h, the culture plates were then incubated in the
chambers (Billups-Rothenberg, CA) ﬂushed with gas mixture contain-
ing 1% O2, 5% CO2 and 94% N2 at 2 p.s.i for 30 min. The humidiﬁed
chambers were sealed and placed at 37 C and incubated further. Con-
trols included parallel cultures in which cells were exposed to normaxia
(21% oxygen tension).
2.3. Gene expression analysis using reverse transcription-polymerase
chain reaction
Reverse transcription-polymerase chain reaction (RT-PCR) was
used to determine the relative amount of mRNA transcript in hypox-
ia-induced LX-2 cells.LX-2 cells were cultured in hypoxia condition
[1% O2 (5% CO2: 94% N2)] for 8 h and 24 h after serum-starvation.
Cells were collected immediately and total RNA was extracted using
Trizon reagent (Gibco BRL, CA) according to manufacturer’s proto-
col. For cDNA synthesis, brieﬂy, 2 lg of total RNA was used to gen-
erate cDNA in each sample using the SuperScript II reverse
transcriptase with oligo dT(12–18) primer (Invitrogen, Gaithersburg,
MD), and then cDNA was puriﬁed using puriﬁcation kit (Qiagen, Ger-
many) according to manufactory’s protocol.
After RT, semi-quantitative RT-PCR ampliﬁcation with Taq poly-
merase was used to estimate the expression of the following genes in
hypoxic LX-2 cells: VEGF, HIF-1a, TIMP-1, MMP-2, TGF-b 1 and
Collagen type I. The speciﬁc primers were designed according to pub-
lished human cDNA sequences using Primer Premier 5 software. The
sequences of primers were listed in Table 1. The ampliﬁcation condi-
tions were the following: a denaturing step at 94 C for 45 s, an anneal-
ing step at 56 C for collagen type I, at 58 C for VEGF, HIF-1a,
TIMP-1 and MMP-2, at 60 C for TGF-b1 for 45 s, and an extension
step at 72 C for 60 s. The optimized number of cycles for speciﬁc
genes was 30 cycles for VEGF, 35 cycles for MMP-2 and HIF-1a,
40 cycles for TIMP-1, TGF-b1 and collagen type I. Samples were ana-
lyzed on 1.5% agarose gel and stained with ethidium bromide. b-Actin
was ampliﬁed as an intrinsic control. Each experiment was performed
in triplicate in independent reactions.
The mRNA level of MMP-2 and TIMP-1 was further analyzed by
quantitative real-time PCR (ABI 7300) using the same batch of total
RNA prepared for RT-PCR. 2 lg of total RNA was subjected to
cDNA synthesis in the presence of SuperScript II reverse transcriptase.
Quantitative assessment of cDNA was carried out by real-time PCR
with a SYBR Green Master Mix Kit (Applied Biosystems). Reactions
were characterized by comparing threshold cycle (CT) values. Samples
with a high starting copy number showed an increase in the ﬂuores-
cence early in the PCR process resulting in a low CT number, whereasTable 1
Primers sequence for RT-PCR
Gene Primer sequence
VEGF Sense 5 0-TAC CTC CAC CAT GCC AAG TG-30
Anti-sense 50-CTC CTG GAA GAT GTC CAC CA-3 0
HIF-1a Sense 5 0-GCG GCG CGA ACG ACA AGA AAA AG-30
Anti-sense 50-GAA TGT GGC CTG TGC AGT GCA ATA C-30
TIMP-1 Sense 5 0-CTG TTG TTG CTG TGG CTG ATA-30
Anti-sense: 50-CCG TCC ACA AGC AAT GAG-30
MMP-2 Sense 5 0-GTA TTT GAT GGC ATC GCT CA-30
Anti-sense 50-CAT TCC CTG CAA AGA ACA CA-3 0
TGF-b1 Sense 5 0-GGC AGT GGT TGA GCC GTG GA-30
Anti-sense 50-TGT TGG ACA GCT GCT CCA CCT-30
Collagen I Sense 5 0-CCC AGA ACA TCA CAT ATC AC-30
Anti-sense 50-CAA GAG GAA CAC ATA TGG AG-3 0
FGFR4 Sense 5 0-GGGTCCTGCTGAGTGTGC-3 0
Anti-sense 50-GGGGTAACTGTGCCTATTCG-3 0
NCOR-2 Sense 5 0-AGCATTCCATCCCTACGGG-30
Anti-sense 50-TGGACCCCTTCACCAAAGC-30
BRCA1 Sense 5 0-CTTTCATCATTCACCCTTGGC-30
Anti-sense 50-ACATCTGCCCAATTGCATGG-3 0a lower starting copy number resulted in higher CT numbers. mRNA
levels were normalized relative to GAPDH values.
2.4. Western blot analysis of collagen type I, a-SMA and p-Smad2
As described above, LX-2 cells induced by hypoxia were lysed for
Western blotting analysis. After centrifugation, the protein content
was determined by the Bradford assay (Bio-Rad Laboratories, CA).
30 lg total protein for each samples was fractionated on 12% SDS–
PAGE gel and transferred to polyvinylidene diﬂuoride (PVDF) mem-
brane. After washing, the membrane was blocked with 5% skimmed
milk at room temperature for 1 h and incubated with mouse polyclonal
antibody against a-SMA, rabbit monoclonal antibody against
p-Smad2 and mouse monoclonal antibody against collagen type I at
4 C overnight. After washing, the immunoblot was incubated with
horseradish peroxidase-conjugated anti-rabbit and anti-mouse anti-
body at room temperature for 1 h. After washing, the bound antibody
was visualized with ECL kit (Amersham Bioscience).
2.5. Gene expression proﬁling using cDNA microarray analysis
2.5.1. Total RNA preparation. Cells (1 · 106) were seeded in a
140 mm cell culture plate for 24 h and then were starved in DMEM
medium supplemented with 0.5% FBS for 24 h. After starvation, cells
were treated under low oxygen tension (1%) for 24 h. Normoxic cells
were used as control. Cells were harvested and total RNA was isolated
with Trizon reagent (Gibco BRL, CA) according to the manufacturer’s
instruction. Total RNA concentration was measured by their absor-
bance at 260 nm. The quality of RNA samples was veriﬁed by exam-
ining the integrity of 28S and 18S rRNA using 1% agarose gel
electrophoresis.
2.5.2. cDNA microarray hybridization. Total RNA from treated or
control samples was reverse-transcribed to cDNA in the presence of
reverse transcriptase (SuperScript II, Invitrogen) During the reaction,
two distinct ﬂuorescent dyes, Cy3-dUTP and Cy5-dUTP (Amersham
Pharmacia Biotech, NJ), were incorporated into the cDNA for the
control and treated samples, respectively. The Cy3 and Cy5 labeled
cDNA were combined and used in a competitive hybridization of a
cDNA microarray containing 9982 human genes and expressed se-
quence tags (Unigen Human Cloneset Version 2.0, Incyte Genomics,
CA). The cDNA microarray was fabricated based on pulished proto-
cols [7].
2.5.3. Gene expression analysis. Microarray images from two-color
ﬂuorescence hybridization were obtained with confocal laser scanner
(ScanArray 4000, GSI Lumnoics, MA) and the images were analyzed
using ScanAlyze (Michael Eisen, Stanford University). Fluorescence
ratios (Cy5 over Cy3) were used to determine the relative level of gene
expression. Genes showed a greater than 2-fold induction or repression
(Cy5/Cy3 ratio above 2 or below 0.5) were selected for further func-
tional analysis. The cutoﬀ value of 2-fold is conventionally used by
other investigators [8].
To validate the expression pattern identiﬁed on the expression array,
three genes (FGFR4, NCOR-2 and BRCA1) were picked and semi-
quantitative RT-PCR was performed to conﬁrm their changed expres-
sion with cDNA templates from LX-2 with and without the treatment
of 1% O2. Brieﬂy, the total RNA was isolated from LX-2 using Trizon
reagent (Gibco BRL, CA) and reverse transcription was carried out by
SuperScript II reverse transcriptase (Invitrogen), as described previ-
ously. The PCR product was analyzed by 1.5% agarose gel electropho-
resis. The semi-quantitative analysis was performed using the volume
analysis in the Quantity One Software (BioRad, USA). Each detected
gene/b-actin quotient is the indication of the detected gene. Experi-
ments were performed for three times with similar results. In addition,
the expression of BRCA1 in hypoxia-induced LX-2 cells was further
veriﬁed by real time-PCR.3. Results
3.1. Expression of HIF-1a and VEGF mRNA in LX-2 cells in
response to hypoxia
Hypoxia can directly regulate gene transcription via binding
of HIF-1, an ab heterodimer, to cis-acting DNA sequences.
Since the a subunit of HIF-1 confers hypoxia inducibility [9],
HIF-1a gene expression was ﬁrst examined in this study. In
O2 tension            21%     1%      21%     1%
8h                  24h
α-SMA
Fig. 2. Eﬀect of hypoxia on a-SMA in HSCs. LX-2 cells were treated
by 1% oxygen tension for 8 h and 24 h. The expression of a-SMA
protein was investigated by Western blotting analysis.
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expression VEGF. To measure HIF-1a and VEGF mRNA
expression levels in human HSCs in response to hypoxia,
LX-2 cells were exposed to 1% oxygen tension for 8 h and
24 h. RT-PCR (Fig. 1) showed that HIF-1a gene expression
was induced after hypoxia treatment. The increase by hypoxia
for 8 h was more intense than that for 24 h, indicating HIF-1a
exhibited a rapid response to hypoxia stress in human HSCs.
In the mean time, the expression of VEGF was upregulated
in hypoxic LX-2 cells and there were no signiﬁcant diﬀerence
between 8 h and 24 h.
3.2. Expression of a-SMA protein in LX-2 cells in response to
hypoxia
a-SMA expression is a marker of ﬁbroblast activation to a
myoﬁbroblastic phenotype, and HSCs a-SMA expression is in-HIF-1α
VEGF
β - Actin
O2 tension           21%     1%    21%    1%
8h              24h
Fig. 1. Hypoxia induction of HIF-1a and VEGF mRNA in HSCs.
LX-2 cells were exposed to 1% oxygen tension for 8 h and 24 h. The
expression of HIF-1a and VEGF gene was analyzed using RT-PCR. b-
Actin was used for the internal standard. The experiments were
repeated three times independently.
MMP-2
TIMP-1
β - Actin
O2 tension           21%      1%      21%      1%
8h                   24h
Fig. 3. Expression change of MMP-2 and TIMP-1 genes in HSCs induced by
24 h. MMP-2 and TIMP-1 mRNA levels were shown using RT-PCR (Fig.
standard. *P < 0.01 vs. 8 h normoxia control; **P < 0.01 vs. 24 h normoxiacreased in ﬁbrotic liver in vivo [10]. Upon hypoxia stimulation,
the expression of a-SMA protein was elevated in LX-2 cells
comparing to normoxic LX-2 cells. There was no signiﬁcant
diﬀerence between 8 h and 24 h hypoxia treatment groups
(Fig. 2). The result suggested that hypoxia might induce the
activation of HSCs.
3.3. Eﬀect of hypoxia on expression of MMP-2 and TIMP-1
mRNA
The changes in mRNA expression of TIMP-1 and MMP-2
were evaluated in LX-2 cells under the treatment of hypoxia
as shown by semi-quantitative RT-PCR (Fig. 3a). MMP-2 is
well known to regulate cell–matrix composition by degrading
components of the ECM [11]. The level of MMP-2 mRNA
expression was upregulated in LX-2 cells induced by either
8 h or 24 h hypoxia treatment. The elevation was slightly stron-
ger in the 8 h group than in the 24 h group. TIMP-1 is a speciﬁc
inhibitor of matrix metalloproteinases which is the key regula-
tor of MMP activity and ECM degradation [12]. Similar to
MMP-2, hypoxia potentiated the expression of TIMP-1 in
LX-2 cells. However, the change of TIMP-1 gene expression
was similar under both 8 h and 24 h hypoxia treatments. Fur-
thermore, the changes of MMP-2 and TIMP-1 mRNA level
were also investigated using quantitative real-time PCR
(Fig. 3b). The regulation patterns of the two genes as measured
by RT-QPCR are consistent with that from RT-PCR.0
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hypoxia. LX-2 cells were incubated at 1% oxygen tension for 8 h and
3a) and real time PCR (Fig. 3b). b-Actin was used for the internal
control, n = 3.
O2 tension           21%          1%         21%       1%
TGF- β1
β - Actin
p-Smad2
8h                          24h
Fig. 5. Eﬀect of hypoxia on TGF-b/Smad signaling pathway in
hypoxic HSCs. LX-2 cells were incubated at 1% oxygen tension for 8 h
and 24 h. (a) Expression of TGF-b1 mRNA level was evaluated using
RT-PCR. (b) Phosphorylation status of Smad2 was shown using
Western blotting.
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To determine whether hypoxia plays a role in the induction
of collagen type I in LX-2 cells, the expression of collagen was
assessed in LX-2 cells under normoxia and hypoxia conditions
by RT-PCR and western blotting techniques (Fig. 4). The
obvious increase in collagen type I gene expression was ob-
served at 24 h of hypoxia whereas hypoxic treatment of 8 h
had no eﬀect on the expression of collagen I gene in LX-2 cells.
For the production of collagen I protein, there was a signiﬁ-
cant elevation after 48 h of hypoxia.
3.5. Eﬀect of hypoxia on TGF-b1 and p-Smad2
TGF-b1 is the key mediator in human ﬁbrogenesis [13]. In
HSCs, TGF-b1 favors the transition to myoﬁbroblast-like
cells, stimulates the synthesis of ECM protein, and inhibits
their degradation through TGF-b/Smad signaling pathway.
To determine the eﬀect of hypoxia on TGF-b/Smad signaling
pathway, the expression of TGF-b1 mRNA and the phosphor-
ylation level of Smad-2 in LX-2 cells under the treatment of
hypoxia were analyzed. Hypoxia treatment led to the upregu-
lation of the expression of TGF-b1 gene in a time-dependent
manner (Fig. 5a). After 24 h hypoxia incubation, TGF-b1
expression was greater than that after 8 h. Furthermore, the
phosphorylation of Smad2 was also induced in 1% oxygen
tension (Fig. 5b). In normoxic HSCs, only low quantity of
p-Smad2 were detected. Hypoxia signiﬁcantly increased
p-Smad2 protein expression after either 8 h or 24 h treatments.
The above results demonstrated that hypoxia might aﬀect
HSCs through potentiating TGF-b1 and Smad signaling path-
way.
3.6. Eﬀects of hypoxia on gene expression proﬁles in HSCs LX-2
cells
To further study the molecular mechanism of hypoxia, the
gene expression proﬁles of human HSCs under the treatment
of 1% oxygen tension were obtained by using a cDNA micro-
array containing 9982 human genes and expressed sequence
tags. Gene expression levels that diﬀered by at least 2-fold were
considered to be diﬀerentially regulated. A total of 45 genes
were revealed to exhibit diﬀerential expression in LX-2 cellsO2 tension           21%      1%       21%       1%
8h                      24h
β - Actin
Collagen I
24h                  48h
Collagen I
Fig. 4. Eﬀect of hypoxia on ECM in HSCs treated by hypoxia. LX-2
cells were incubated at 1% oxygen tension for the indicated time.
mRNA and protein level of conllagen type I was analyzed by RT-PCR
and Western blotting, respectively.treated with hypoxia as compared to normoxic LX-2 cells
(Table 2). Of the 45 genes, 32 genes showed elevated expression
levels, whereas 13 genes showed reduced expression levels.
Functional analysis identiﬁed some diﬀerentially expressed
genes that are involved in proliferation, signaling, inﬂamma-
tion and ﬁbrosis.
To further investigate the reliability of the microarray data,
three diﬀerentially expressed genes were chosen and their
expression levels were measured by RT-PCR. Because hypoxia
might play an important role in ﬁbrogenesis, transcription, sig-
nal transduction, and carcinoma, relative genes including
ﬁbroblast growth factor receptor 4 (FGFR4), nuclear receptor
co-repressor 2 (NCOR2) and breast cancer 1 (BRCA1) was se-
lected to verify the microarray data. Fig. 6a shows that the
expression patterns of these three genes as determined by
RT-PCR were similar to those determined by cDNA micro-
array technique. Furthermore, the expression change of
BRCA1 with the treatment of low oxygen tension showed by
real time PCR reinforced the microarray (Fig. 6b).4. Discussion
It is well known that hypoxia is a key factor for cell damage
and plays a role in acute and chronic liver injury. Liver ﬁbrosis
represents a wound–healing process in response to a variety of
chronic injurious stimuli. Following a ﬁbrogenic stimuli,
HSCs, mainly responsible for the increased synthesis and
deposition of ECM in the ﬁbrotic liver, undergo a complex
activation process. Thus, hypoxia, as a result of microvascular
compromise, may play an important role in the pathogenesis
of ﬁbrosis. To further analyze hypoxia induced changes rele-
vant to ﬁbrogenesis, the in vitro eﬀect of 1% O2 on HSCs
was evaluated.
In this report, we showed that LX-2, which is a well-charac-
terized model of human HSCs, upregulated HIF-1a in
response to hypoxia stimuli (Fig. 1). HIF-1 was initially
identiﬁed as the transcription factor permitting the induction
of erythropoietin (EPO) gene by hypoxia and is now consid-
ered to be the major regulator of about 100 physiologically
important genes among them the angiogenesis mediator
VEGF or plasminogen activator innibitor-1 (PAI-1) [14]. We
Table 2
Signiﬁcantly changed genes in HSCs response to hypoxia
Gene name Gene
symbol
Ratio
(Cy5/Cy3)
GenBank Potential gene Function
Homo sapiens Rho-associated, coiled-coil
containing protein kinase 2
ROCK2 7.49 NM_004850.3 Protein kinase that phosphorylates a large number
of important signaling proteins
H. sapiens deltex homolog 2 (Drosophila) DTX2 4.90 BC008856.2 Ligase activity
H. sapiens NADH dehydrogenase (ubiquinone)
Fe–S protein 2, 49 kDa (NADH-coenzyme
Q reductase)
NDUFS2 4.53 BC001456.1 Transfer of electrons from nadh to the respiratory
chain
UDP-glucose dehydrogenase UDPGDH 4.38 AF_049126 Converts UDP-glucose to UDP-glucutonate
H. sapiens RAB3A, member RAS oncogene
family
RAB3A 3.30 NM_002866.3 Involved in exocytosis by regulating a late step in
synaptic vesicle fusion
H. sapiens UDP-Gal:betaGlcNAc beta
1,4-galactosyltransferase, polypeptide 5
B4GALT5 3.18 NM_004776.2 Responsible for the synthesis of complex-type
n-linked oligosaccharides in many glycoproteins as
well as the carbohydrate moieties of glycolipids
H. sapiens vascular endothelial growth
factor gene
VEGF 3.15 AF437895.1 Angiogenesis
H. sapiens phospholipase C-like 4 PLCL4 3.13 BC019679.1 Mediate the production of the second messenger
molecules diacylglycerol (dag) and inositol
1,4,5-trisphosphate (ip3)
H. sapiens serine/threonine kinase 25 STK25 3.04 BC091505.1 Oxidant stress-activated serine/threonine kinase that
may play a role in the response to environmental
stress
H. sapiens mRNA for lectin, mannose-binding,
1 precursor variant
LMAN1 2.97 AK223208.1 Mannose-speciﬁc lectin, may be involved in the
sorting or recycling of proteins, lipids, or both
H.sapiens XAP-4 mRNA for GDP-dissociation
inhibitor
XAP-4 2.90 X79353.1 Regulate the GDP–GTP exchange reaction of
members of the rab family
H. sapiens signal recognition particle 54 kDa SRP54 2.77 NM_003136.2 Binds to the signal sequence of presecretory protein
H. sapiens MAWD binding protein MAWBP 2.75 AB049758.1 Catalytic activity
H. sapiens polymerase epsilon 2 (p59 subunit) POLE2 2.71 NM_002692.2 Participates in DNA repair and in chromosomal
DNA replication
H. sapiens potassium inwardly-rectifying channel,
subfamily J, member 5
KCNJ5 2.70 NM_000890.3 Inward rectiﬁer potassium channels
H. sapiens chloride channel 7 CLCN7 2.62 BC006158.1 Voltage-gated chloride channel. Chloride channels
have several functions including the regulation of
cell volume; membrane potential stabilization, signal
transduction and transepithelial transport
H. sapiens sodium channel, voltage-gated,
type V, alpha
SCN5A 2.61 NM_000335.3 Mediates the voltage-dependent sodium ion
permeability of excitable membranes
H. sapiens peroxisomal acyl-CoA thioesterase,
transcript variant 3
PTE1 2.58 NM_183386.1 Catalyze the hydrolysis of acyl-coas to the free
fatty acid and coenzyme a
H. sapiens ubiquitin-activating enzyme E1-like UBE1L 2.50 NM_003335.2 Activates ubiquitin
H. sapiens mRNA for Fibroblast growth factor
receptor 4 variant protein
FGFR4 2.47 AB209631.1 Receptor for acidic ﬁbroblast growth factor
H. sapiens chemokine (C-X-C motif) ligand 13
(B-cell chemoattractant)
CXCL13 2.46 NM_006419.1 Chemotactic for b-lymphocytes
H. sapiens megalencephalic
leukoencephalopathy with subcortical
cysts 1 (MLC1), transcript variant 2
MLC1 2.35 NM_139202.1 May be a transporter
H. sapiens mRNA for ﬁbulin-2 FBLN2 2.35 X82494.1 Extracellular matrix protein, binding to ﬁbronectin
and some other ligands is calcium dependent
H. sapiens zinc ﬁnger protein 33A ZNF33A 2.30 NM_006974.1 Involved in transcriptional regulation
H. sapiens interferon induced with
helicase C domain 1
IFIH1 2.29 NM_022168.2 RNA helicases
H. sapiens mRNA for nuclear receptor
co-repressor 2 variant protein
NCOR2 2.19 AB209089.1 Mediates the transcriptional repression activity of
some nuclear receptors
H. sapiens zona pellucida binding protein ZPBP 2.12 NM_007009.1 Binding of sperm to zona pellucida
H. sapiens transmembrane protein 9 TMEM9 2.08 NM_016456.2 Involved in intracellular transport
H. sapiens death eﬀector domain containing
transcript variant 1
DEDD 2.08 NM_032998.1 Programmed cell death
H. sapiens matrix metalloproteinase 2 MMP2 2.05 NM_004530.1 Breakdown of extracellular matrix
H. sapiens SUMO1/sentrin speciﬁc protease 5 SENP5 0.49 NM_152699.2 Cysteine-type peptidase activity
H. sapiens SUMO1/sentrin speciﬁc protease 5 SENP5 0.49 NM_152699.2 Cysteine-type peptidase activity
Betainehomocysteine methyl transferase BHMT 0.49 BC012616.1 Homocysteine homeostasis
H. sapiens N-acetylneuraminic acid synthase NANS 0.48 BC000008.2 Sialic acid synthase
H. sapiens C-terminal binding protein 1 CTBP1 0.47 BC053320.1 A transcriptional repressor and may play
a role during cellular proliferation
H. sapiens dual speciﬁcity phosphatase 8
serine/threonine-protein phosphate
DUSP8 0.42 NM_004420.1 Dual speciﬁcity protein phosphatase and negatively
regulate members of the mitogen-activated protein
(MAP) kinase superfamily
H. sapiens myxovirus (inﬂuenza virus)
resistance 2 (mouse)
MX2 0.39 NM_002463.1 Interferon-induced GTP-binding protein
(continued on next page)
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Table 2 (continued)
Gene name Gene
symbol
Ratio
(Cy5/Cy3)
GenBank Potential gene Function
H. sapiens transcription elongation
factor A (SII), 1
TCEA1 0.35 NM_006756.2 Necessary for eﬃcient rna polymerase ii
transcription elongation past template-encoded
arresting sites
Human BRCA1, Rho7 and vatI genes BRCA1 0.34 L78833.1 Plays a central role in DNA repair by facilitating
cellular response to DNA repair
H. sapiens somatostatin receptor
2 (SSTR2) gene
SSTR2 0.25 AY236542.1 Receptor for somatostatins-14 and 28
H. sapiens hypothetical protein SP192 SP192 5.11 NM_021639.3 Unknown
H. sapiens hypothetical protein HSPC268 2.24 NM_197964.1 Unknown
H. sapiens similar to SET protein
(Phosphatase 2A inhibitor I2PP2A)
LOC389168 0.45 Hs.449190 Unknown
H. sapiens BAC clone RP11-343H10 from 2 EST 0.40 AC018712.5 Unknown
Homo sapiens Myb-like, SWIRM
and MPN domains 1
KIAA1915 0.40 BX537912.1 Unknown
NCOR-2
BRCA1
β - Actin
FGFR4
O2 tension         21%             1%
24h
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Fig. 6. Electrophoresis analysis of RT-PCR product. Fibroblast growth factor receptor 4 (FGFR4), nuclear receptor co-repressor 2 (NCOR2) and
breast cancer 1 (BRCA1) were selected for the veriﬁcation of microarray data. mRNA expression level were analyzed by RT-PCR with b-actin as
internal control for normalization.
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VEGF may be an important angiogenesis factor during hepa-
tic injury. In response to liver injury, VEGF may enhance the
regenerative potential of residual hepatocytes and that of non-
parenchymal cells [15]. Thus, the induction of VEGF in hyp-
oxic stellate cells may be an early and critical event during
hepatic wound healing and hepatocarcinogenesis. In addition,
a-SMA, the marker of the HSCs activation, was increased un-
der hypoxia conditions, demonstrating the involvement of hy-
poxia in the activation of HSCs (Fig. 2).
We also studied the eﬀect of hypoxia on ECM and its rele-
vant genes. During ﬁbrosis, the components and quantity of
ECM will change and type I and III collagen will increase sig-
niﬁcantly. Fibril-forming ECM also accelerates HSCs activa-
tion through interaction with integrins, the classic ECM
receptors, and binding to at least one tyrosine kinase receptor
(RTK) [16]. Our present data showed that hypoxia increased
the protein expression of collagen type I (Fig. 4). In addition,
a major group of enzymes responsible for ECM degradation is
the MMPs family [17]. TIMPs, speciﬁc inhibitors of MMPs,
have been identiﬁed as the important regulators of MMP
activity and ECM degradation. MMPs and TIMPs play
important roles in various ﬁbrotic diseases. Expression of
TIMP-1 and MMP-2 is increased in hepatic ﬁbrosis which re-ﬂects the changes of liver ﬁbrosis [18]. In our study, RT-PCR
results showed that hypoxia increased the expression of TIMP-
1 and MMP-2 genes (Fig. 3). The change of MMP-2 expres-
sion at 8 h of hypoxia is greater than that at 24 h of hypoxia,
suggesting that the eﬀect of hypoxia on ECM metabolism was
more prominent at the early stage of the liver damage.
It is well known that activation of stellate cells contributes to
hepatic ﬁbrosis and TGF-b1 is the most potent ﬁbrogenic fac-
tor. Several studies have reported that modulation of oxygen
tension was recognized as an important regulator of gene acti-
vation of TGF-b in rat brain and liver, and human ﬁbroblast
and hepatoma cells [19–22]. Recently, it was also reported that
cell response to hypoxia involved signaling via Smad protein in
hypoxia endogelial cells by producing TGF-b with autocrine
regulation [23,24]. In this study, we measured the expression
level of TGF-b1 and the phosphorylation level of its down-
stream protein Smad2 in order to reveal the relationship
between hypoxia and intracellular TGF-b signal transduction
during ﬁbrogenesis. In normal HSCs, a weak phosphorylation
of Smad2 was detected. After hypoxic stimulation, the phos-
phorylation status of Smad2 was signiﬁcantly increased in
HSCs. In the mean time, the expression of TGF-b1 mRNA
was upregulated in a time-dependent manner. While the
expression of TGF-b1 under the treatment of hypoxia for
ECM Synthesis
Activated HSCs
Hypoxia NCOR2
pSmads
MMPs
TIMPs
TGF-β
FBLN2
UDPGDH
B4GALT5
BHMT
Fig. 7. A tentative scheme of HSCs activation pathway involved in
cellular response to low oxygen tension.
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Smad2 was more intense in 8 h group (Fig. 5). The results indi-
cated that hypoxia potentiated TGF-b expression and rapidly
induced signaling transduction through Smad/ TGF-b path-
way in HSCs. Furthermore, we also observed an increase in
the expression of a-SMA in HSCs under low oxygen tension,
suggesting the sequence of events where hypoxia induced acti-
vation of HSCs led to the activation of Smad/ TGF-b signal
transduction pathway and production of ﬁbroblastic marker.
To further investigate the molecular mechanism of the acti-
vating eﬀect of hypoxia on HSCs, cDNA microarray was used
to study the gene expression proﬁling of HSCs under the
induction of low oxygen tension. The results provided some in-
sight into how gene expression in human HSCs responded to
hypoxia (Table 2). Analysis of the diﬀerentially expressed
genes showed that the up/downregulated genes triggered by
hypoxia can be clustered into diﬀerent functional groups.
Some genes have been identiﬁed to be responsible for ﬁbrosis
such as MMP-2. VEGF involved in angiogenesis was also ob-
served in hypoxic HSCs. Among the elevated genes, serine/
threonine 25 (STK25) is the oxidate stress-activated serine/
threonine kinase that may play a role in the environmental
stress. For example, it was reported that STK25 can be in-
duced by sodium arsenite, which is an environmental impor-
tant carcinogen that poses a signiﬁcant health risk in humans
[25]. Because low oxygen tension is also the negative factor
for mammalian cells, hypoxia stress is expected to induce the
expression of stress responsive genes such as STK25.
The above data showed that hypoxia induced the activation
of HSCs and accelerate the deposition of ECM. Among the
upregulated genes, some are relevant to the formation and
remodeling of ECM and involved in the regulation of cellular
response to ECM, including MMP-2, ﬁbulin-2 (FBLN2),
UDP-glucose dehydrogenase (UDPGDH) and UDP-galacto-
syltransferase polypeptide 5 (B4GALT5). UDPGDH converts
UDP-glucose to UDP-glucutonate, a critical component of
the glycosaminoglycans, hyluronan, chondroitin sulfate and
heparan sulfate [26]. It is known that heparan sulfate proteogly-
cans are essential cofactors in cell–matrix adhesion processes,
in cell–cell recognition system and in receptor-growth factor
interactions. Human HSCs can synthesize all four cyndecans
and the increased expression of glycosaminoglycans and hyalu-
ronic acid may be important in the deposition of ECM and acti-
vation of growth factors accompanying ﬁbrogenesis [27]. Thus,
our results demonstrated that the increased expression of hep-
aran sulfate proteoglycans in activated HSCs might be induced
by elevated UDP-glucose dehydrogenase caused by hypoxia. In
additional, the function of B4GALT5 may be responsible for
the synthesis of n-linked oligosaccharides in many glycopro-
teins. However, to date, the deﬁnitive role of B4GALT5 is still
unclear. Our data showed that B4GALT5 may also participate
in metabolic response of cells under hypoxic stress.
Another interesting gene is ﬁbroblast growth factor receptor
4 (FGFR4). The extracellular portion of the protein interacts
with ﬁbroblast growth factors (FGF), setting in motion a cas-
cade of downstream signals, ultimately inﬂuencing mitogenesis
and diﬀerentiation. The expression of FGFR4 was increased in
hepatic ﬁbrotic rats induced by thioacetamide [28]. Recently,
an agonist role for FGF1 and FGF2 is seen in speciﬁcally in-
sult-induced liver matrix deposition and hepatic ﬁbrogenesis
and as a potential target for the prevention of hepatic ﬁbrosis
by acute CCl4 exposure [29].Among the downregulated genes, breast cancer 1 (BRCA1)
is a nuclear phosphoprotein that plays a role in maintaining
genomic stability and acts as a tumor suppressor. BRCA1
combined with other tumor supppressors, DNA damage sen-
sors, and signal transducer to form a large multi-subunit pro-
tein complex known as BASC. The reduced expression of
BRCA1 in colorectal cancer liver metastasis was observed
[30]. However, few report described the role of BRCA1 in
HSCs. Our data showed that hypoxia decreased the expression
of BRCA1, but it is unknown whether it may exert certain
function in activated HSCs. Nuclear receptor co-repressor 2
(NCOR2) mediated the transcriptional repression activity of
some nuclear receptors by promoting chromatin condensation,
thus preventing access of the basal transcription. NCOR2 can
form a large corepressor complex and this complex associates
with the thyroid and the retinoid acid receptor. NCOR2 might
be the novel TGF-b responsive gene and it has been showed
that exogenous TGF-b could upregulate the gene expression
of NCOR2 [31]. Thus, the upregulated gene expression of
NCOR2 in low oxygen tension may result from hypoxia-
induced expression of TGF-b.
Reduced mRNA expression was also observed for betaine-
homocysteine methyl transferase (BHMT). BHMT is a key
liver enzyme responsible for homocysteine (Hcy) homeostasis.
It utilizes Hcy as a substrate and converts Hcy back to methi-
onine. Hyperhomocysteinemia may develop as a consequence
of defects in Hcy-metabolizing genes (such as BHMT); nutri-
tional conditions leading to vitamin B (6), B (12), or folate
deﬁciencies; or chronic alcohol consumption. Elevated plasma
levels of Hcy have been shown to interfere with normal cell
function in a variety of tissues and organs, such as the vascular
wall and the liver. It is known that Hcy is able to induce the
expression and synthesis of the TIMP-1 in variety of cell types
ranging from vascular smooth muscle cells to hepatocytes,
HepG2 cells and HSCs. In HSCs, Hcy also stimulates alpha1
(I) procollagen mRNA expression, promotes activating pro-
tein-1 (AP-1) binding activity [32]. In addition, it has been re-
ported that the gene expression of BHMT was upregulated in
activated primary mouse HSCs [33]. We hypothesized that
alterations in Hcy metabolism in liver ﬁbrosis can be ascribed
in part to the reduced expression BHMT gene in hypoxia-in-
duced HSCs.
Since hypoxia could lead to the activation of HSCs, a key
event of ﬁbrogenesis, microarray data provide gene expression
proﬁles related to hypoxia-induced HSCs activation so that
210 Y.-F. Shi et al. / FEBS Letters 581 (2007) 203–210potential genes related to ﬁbrosis were identiﬁed. Fibrosis may
be inhibited and alleviated through regulating or mediating
these genes and its upstream/downstream factors and genes.
Thus, this information might be helpful for the development
of the anti-ﬁbrotic therapeutic agents.
In summary, hypoxia as the environmental stress factor can
activate oxygen-sensing HSCs. Based on the results obtained
in this study, we proposed a tentative scheme of HSCs activa-
tion pathways involved in cellular response to hypoxia (Fig. 7).
Upon low oxygen tension, the ECM protein levels were in-
creased as well as their regulated genes such as MMP-2 and
TIMP-1. The expression of TGF-b1 was potentiated and Smad
signaling transduction pathway was activated under hypoxic
conditions. A number of genes related to stress response,
metabolism, and ﬁbrogenesis were also found to be regulated
by hypoxia.
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